Published on

98. Ophthalmology – Intraoperative Floppy Iris Syndrome (IFIS)

Basics

Description

Intraoperative floppy iris syndrome (IFIS) is an abnormal iris behavior encountered during cataract surgery. It may be suspected before surgery when the pupil dilates poorly, but it is primarily an intraoperative diagnosis.

The classic features are:

  • Billowing of the iris stroma during normal irrigation
  • Prolapse of the iris toward or through the corneal incisions
  • Progressive intraoperative miosis
  • Poor maintenance of pupillary dilation despite mechanical stretching

Pupillary stretching alone is often ineffective because the problem is not simply a small pupil, but loss of normal iris dilator tone.


Epidemiology

IFIS occurs more commonly in men than women, largely because medications strongly associated with IFIS are frequently prescribed for benign prostatic hyperplasia.

In the United States, IFIS has historically been reported in approximately 2–3% of cataract operations, although the true frequency varies depending on patient population and medication exposure.


Risk Factors

The strongest risk factor is exposure to α1-adrenergic antagonists, especially drugs with strong activity at the α1A receptor.

The medication most strongly associated with IFIS is tamsulosin (Flomax). A very high proportion of patients exposed to tamsulosin may demonstrate some degree of IFIS during cataract surgery.

Other α1 antagonists associated with IFIS include:

  • Alfuzosin
  • Silodosin
  • Terazosin
  • Doxazosin
  • Naftopidil

Nonselective α1 antagonists generally appear to carry a lower risk than tamsulosin.

Other reported medication associations include:

  • Finasteride
  • Dutasteride
  • Saw palmetto
  • Certain antipsychotic medications

The relationship is strongest and best established with α1 blockers, particularly tamsulosin.


Important Medication History

Patients should be asked specifically about both current and previous use of medications associated with IFIS.

This is important because IFIS may occur:

  • After only a short period of drug exposure
  • Even when the medication was discontinued long before cataract surgery

Therefore, simply asking whether the patient is currently taking tamsulosin is not sufficient.


General Prevention

The most important preventive measure is preoperative recognition.

The ophthalmic surgeon should know whether the patient has ever taken medications associated with IFIS so that the surgical technique and equipment can be planned accordingly.

Avoiding unnecessary exposure to high-risk medications before cataract surgery may reduce risk, but many patients require these drugs for important systemic conditions.

Stopping the medication shortly before surgery does not reliably prevent IFIS.


Pathophysiology

The iris dilator muscle is partly controlled by α1A-adrenergic receptors.

Selective α1A antagonists such as tamsulosin reduce sympathetic stimulation of the iris dilator muscle.

This may produce:

  • Reduced iris dilator tone
  • Poor pharmacologic dilation
  • Increased iris mobility
  • Progressive pupillary constriction during surgery

Chronic exposure may also be associated with structural or functional changes in the iris dilator muscle, which helps explain why IFIS can persist even after the medication is discontinued.


Etiology

IFIS is most commonly associated with exposure to medications that antagonize α1 receptors.

Even relatively brief exposure has been associated with the syndrome.

The condition can persist long after discontinuation, so the relationship cannot always be prevented simply by stopping the medication before surgery.


Commonly Associated Conditions

Conditions commonly treated with medications associated with IFIS include:

  • Benign prostatic hyperplasia
  • Prostate-related urinary symptoms
  • Urinary retention
  • Hypertension
  • Hair loss
  • Certain psychiatric disorders

Because benign prostatic hyperplasia becomes increasingly common with age, IFIS is particularly relevant in the elderly male cataract population.


Geriatric Considerations

Benign prostatic hyperplasia is extremely common in older men.

As a result, a substantial number of elderly men presenting for cataract surgery have current or previous exposure to α1 blockers.

Every older cataract patient, especially a man, should therefore be asked specifically about medications used for urinary or prostate symptoms.


Diagnosis

History

The most important diagnostic step before surgery is a careful medication history.

Ask about:

  • Tamsulosin
  • Alfuzosin
  • Silodosin
  • Terazosin
  • Doxazosin
  • Other prostate or urinary medications
  • Finasteride or dutasteride
  • Saw palmetto
  • Antipsychotic medications

Past use is just as important as current use.


Physical Examination

Poor or slow pharmacologic pupillary dilation before cataract surgery may suggest an increased risk of IFIS.

However, a patient can have apparently adequate preoperative dilation and still develop IFIS intraoperatively.

Therefore, the absence of a small pupil before surgery does not rule out the syndrome.


Intraoperative Findings

The classic intraoperative findings are:

Billowing Iris

The iris becomes unusually mobile and undulates with irrigation currents.

Iris Prolapse

The floppy iris may move toward or prolapse through the main corneal incision or side-port wounds.

Progressive Miosis

The pupil gradually becomes smaller during the operation despite initially adequate dilation.

Poor Response to Stretching

Mechanical stretching of the pupil may temporarily enlarge it but usually does not provide stable dilation throughout surgery.


Differential Diagnosis

A small pupil before surgery can also result from:

  • Previous ocular trauma
  • Chronic uveitis
  • Posterior synechiae
  • Previous infection
  • Chronic miotic therapy
  • Pseudoexfoliation
  • Other iris structural abnormalities

Iris prolapse can also occur because of:

  • Poor wound construction
  • Very short corneal tunnels
  • Excessive intraocular pressure
  • Excessive irrigation pressure

The combination of billowing, prolapse, and progressive miosis, especially in a patient with α1-blocker exposure, strongly supports IFIS.


Treatment and Surgical Management

Management begins with anticipating the syndrome before the operation.

The surgeon should modify the pharmacologic, viscoelastic, fluidic, and mechanical aspects of cataract surgery according to severity.


Stopping the Associated Medication

Stopping tamsulosin or another α1 antagonist before surgery may improve pharmacologic dilation in some patients, but it does not reliably reduce the severity of IFIS.

For this reason, many surgeons do not routinely discontinue these medications.

Any decision to stop a systemic medication should also consider why the medication was prescribed and should generally be coordinated with the prescribing physician.


Preoperative Atropine

Preoperative atropine may improve pupillary dilation and help maintain iris tone in selected patients.

However, atropine does not reliably prevent IFIS, especially in more severe cases.

Therefore, it should not be relied upon as the sole preventive strategy.


Intracameral Adrenergic Agents

Intracameral adrenergic stimulation can improve iris tone.

Agents may include preservative-free intracameral epinephrine or phenylephrine, depending on availability and surgical protocol.

These drugs may:

  • Improve pupillary dilation
  • Increase iris rigidity
  • Reduce progressive miosis
  • Reduce iris billowing

Only appropriate preservative-free intracameral preparations should be used.


Ophthalmic Viscoelastic Devices

Highly cohesive ophthalmic viscoelastic devices can mechanically stabilize the iris and maintain pupillary dilation.

A highly viscous OVD such as sodium hyaluronate 2.3% may help:

  • Expand the pupil
  • Push the iris away from the surgical incision
  • Reduce iris billowing

Other viscoelastic formulations that remain in the anterior chamber during higher fluid flow may also be useful.

Repeated reinjection may sometimes be necessary during surgery.


Wound Construction

A well-constructed, sufficiently long corneal tunnel helps reduce iris prolapse.

Short, unstable, or poorly positioned incisions may make iris prolapse more likely.

Careful wound architecture is therefore an important component of IFIS management.


Fluidics

Lower and more controlled fluidic parameters can reduce movement of the floppy iris.

The surgeon may reduce:

  • Irrigation pressure
  • Aspiration flow
  • Vacuum

Gentler fluidics decrease turbulence and reduce the tendency of the iris to billow or prolapse.


Pupil Expansion Rings

Mechanical pupil expansion is often the most reliable treatment for moderate or severe IFIS.

Devices include various pupillary expansion rings, with the Malyugin ring being one commonly used example.

These rings provide stable enlargement of the pupil throughout surgery and reduce the risk of progressive miosis.


Iris Hooks

Iris retractors or hooks can also mechanically enlarge and stabilize the pupil.

They are especially useful when:

  • The pupil is very small
  • The iris is markedly floppy
  • A pupil expansion ring is unsuitable
  • Asymmetric dilation is desired

Mechanical expansion should be used early rather than after substantial intraoperative miosis or repeated iris prolapse has already occurred.


Why Pupillary Stretching Alone Is Usually Inadequate

Simple mechanical stretching may enlarge the pupil temporarily but does not correct the underlying loss of iris dilator tone.

Consequently, the pupil may constrict again during surgery.

For this reason, stable mechanical devices such as iris hooks or pupil expansion rings are usually more effective in significant IFIS.


Patient Education

Patients taking or previously exposed to α1 blockers should be informed that these medications may complicate cataract surgery.

They should be instructed to tell their ophthalmologist if they have ever taken medications such as:

  • Tamsulosin
  • Alfuzosin
  • Silodosin
  • Terazosin
  • Doxazosin

This history remains important even if the medication was stopped months or years earlier.

Prescribing physicians should also be aware of the association and, when practical, may consider ophthalmic evaluation in patients with known cataract before initiating long-term α1-blocker therapy.


Prognosis

When the surgeon knows about the risk beforehand and uses appropriate surgical modifications, cataract surgery can usually be completed successfully.

The greatest difficulty occurs when significant IFIS develops unexpectedly.

Preoperative recognition therefore substantially improves surgical safety.


Complications

IFIS increases the risk of intraoperative complications, particularly when it is unanticipated.

Potential complications include:

  • Posterior capsule rupture
  • Vitreous loss
  • Iris trauma
  • Iris prolapse
  • Irregular or damaged pupil
  • Prolonged surgery
  • Increased postoperative inflammation

The complication rate is highest when the surgeon is unaware of prior exposure to an associated medication.


High-Yield Clinical Pearls

IFIS classically causes billowing iris, iris prolapse, and progressive intraoperative miosis.

Tamsulosin is the medication most strongly associated with IFIS.

Ask about previous as well as current α1-blocker use.

Stopping tamsulosin shortly before surgery does not reliably eliminate the risk.

Preoperative atropine may help but does not reliably prevent IFIS.

Intracameral adrenergic agents, controlled fluidics, cohesive viscoelastic, iris hooks, and pupil expansion rings are important management strategies.

The greatest surgical risk occurs when IFIS is unexpected rather than when it is recognized and planned for in advance.



Image description
0 Comments